Sarcopenia as a predictor of chemotherapy toxicity in patients with ovarian cancer receiving platinum and taxane-based chemotherapy.

被引：0
|
作者：
Tucker, Katherine
Staley, Stuart-Allison Moffat
Newton, Meredith
Ertel, Michelle
Zhang, Yingao
Doherty, Irene
Gehrig, Paola A.
机构：
[1] Univ N Carolina, Div Gynecol Oncol, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[3] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA
[4] CHEORS, Chapel Hill, NC USA
[5] Univ N Carolina, Chapel Hill, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e17035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17035
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sarcopenia as a predictor of survival in patients with epithelial ovarian cancer (EOC) receiving platinum and taxane-based chemotherapy.
    Staley, Stuart-Allison Moffat
    Tucker, Katherine
    Newton, Meredith
    Ertel, Michelle
    Zhang, Yingao
    Doherty, Irene
    Gehrig, Paola A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Visceral adiposity as a predictor of chemotherapy toxicity in patients with ovarian cancer receiving platinum and taxane-based chemotherapy
    Tucker, K.
    Staley, A.
    Oldan, J. D.
    Newton, M.
    Ertel, M.
    West, L.
    Moore, D. T.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 112 - 113
  • [3] Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy
    Staley, S. Allison
    Tucker, Katherine
    Newton, Meredith
    Ertel, Michelle
    Oldan, Jorge
    Doherty, Irene
    West, Lindsay
    Zhang, Yingao
    Gehrig, Paola A.
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 695 - 700
  • [4] Visceral adiposity as a predictor of survival in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy.
    Staley, Stuart-Allison Moffat
    Tucker, Katherine
    Oldan, Jorge
    Moore, Dominic T.
    Newton, Meredith
    Ertel, Michelle
    West, Lindsay
    Bae-Jump, Victoria
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Predicting toxicity of platinum and taxane-based chemotherapy in older patients with gynecologic cancer
    Yoshida, Hiroyuki
    Shintani, Daisuke
    Kawashima, Naoyuki
    Fujiwara, Keiichi
    JOURNAL OF BUON, 2020, 25 (02): : 736 - 742
  • [6] Coping with the burden of taste alteration, a toxicity of taxane-based chemotherapy.
    Speck, Rebecca M.
    DeMichele, Angela
    Farrar, John T.
    Hennessy, Sean
    Mao, Jun
    Stineman, Margaret G.
    Barg, Frances K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane-Based Chemotherapy for Early-Stage Breast Cancer
    Shachar, Shlomit Strulov
    Deal, Allison M.
    Weinberg, Marc
    Williams, Grant R.
    Nyrop, Kirsten A.
    Popuri, Karteek
    Choi, Seul Ki
    Muss, Hyman B.
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3537 - 3543
  • [8] ESTROGEN RECEPTOR BETA AS A PREDICTIVE MARKER IN OVARIAN CANCER PATIENTS TREATED WITH PLATINUM AND TAXANE-BASED CHEMOTHERAPY
    Bogush, T.
    Basharina, A.
    Dudko, E.
    Vikhlanceva, N.
    Vorobjeva, I.
    Bogush, E.
    Tjulandina, A.
    Davydov, M.
    Tjulandin, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1803 - 1803
  • [9] Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy
    van Draanen, J.
    Stacey, E.
    Dent, R.
    Gallo-Hershberg, D.
    Pasetka, M.
    Giotis, A.
    Kan, K.
    van Draanen, L.
    Fang, T.
    Lee, V.
    Walker, S.
    DeAngelis, C.
    CANCER RESEARCH, 2010, 70
  • [10] Pharmacogenetics as a predictor chemotherapy induced peripheral neuropathy in gynecologic cancer patients treated with Taxane-based chemotherapy
    Mysona, David
    Dorr, Katherine
    Ward, Alex
    Shaver, Ellen
    Rungruang, Bunja
    Ghamande, Sharad
    GYNECOLOGIC ONCOLOGY, 2023, 168 : 114 - 118
12345